Unspecified SGLT2 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified SGLT2 inhibitor, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers [Phase 1]